Cardiff Oncology Files 2024 10-K
Ticker: CRDF · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1213037
| Field | Detail |
|---|---|
| Company | Cardiff Oncology, Inc. (CRDF) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotech
Related Tickers: CRDF
TL;DR
CRDF 2024 10-K filed. Financials and biz ops for FY24 detailed.
AI Summary
Cardiff Oncology, Inc. filed its 2024 10-K on February 27, 2025, reporting its fiscal year ended December 31, 2024. The company, formerly known as Trovagene, Inc., is focused on biological products. Key financial data and operational details for the fiscal year 2024 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Cardiff Oncology's financial performance and business operations for the fiscal year 2024, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Cardiff Oncology faces inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-27 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Cardiff Oncology, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- Trovagene, Inc. (company) — Former company name
- 2836 (industry_code) — Standard Industrial Classification for Biological Products
FAQ
What is Cardiff Oncology's primary business focus?
Cardiff Oncology, Inc. is focused on biological products, specifically within the 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' industry, SIC code 2836.
When did Cardiff Oncology file its 10-K for the fiscal year 2024?
Cardiff Oncology filed its 10-K for the fiscal year ended December 31, 2024, on February 27, 2025.
What was Cardiff Oncology's former company name?
Cardiff Oncology, Inc. was formerly known as Trovagene, Inc., with previous name changes from TrovaGene Inc. and XENOMICS INC.
What is the company's principal business address?
The company's business address is 11055 Flintkote Avenue, San Diego, CA 92121.
What is the Standard Industrial Classification (SIC) code for Cardiff Oncology?
The SIC code for Cardiff Oncology is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Cardiff Oncology, Inc. (CRDF).